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Abstract 
Objective: Most of the commercially available fluoride varnishes (FV) have not been 
evaluated for their cariostatic properties. Consequently, the aim of this in vivo study was 
to investigate intra-oral fluoride retention and clearance patterns from three different FV. 
Methods: Eighteen subjects (7-11 years) participated in a laboratory analyst-blinded, 
randomized, crossover study comparing the ability of 5% sodium fluoride varnishes 
(CavityShield-CS, Enamel Pro-EP, Vanish-V) to enhance fluoride concentrations in 
biofilm fluid, centrifuged and whole saliva over a period of 48h after a single FV 
application.  
Results: Similar fluoride concentration × time patterns were noted for all investigated FV 
and studied variables, with the highest fluoride concentrations observed for the first 
biological sample collected after FV application (30min). Mean±SE (area under fluoride 
clearance curve) values were (µg F/g or ml × min): biofilm fluid – CS (472±191), EP 
(423±75), V (1264±279); centrifuged saliva – CS (42±7), EP (19±3), V (41±8); whole 
saliva – CS (68±11), EP (64±10), V (60±7). V delivered more fluoride to biofilm fluid 
than CS (p=0.0116) and EP (p=0.0065), which did not differ (p=0.27). For centrifuged 
saliva, CS and V were not significantly different (p=0.86), but resulted in higher fluoride 
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retention than EP (p<0.0008). No significant differences among FV were observed for 
whole saliva (p=0.79).  
Conclusion: The present study has shown that FV vary in their ability to deliver fluoride 
intra-orally potentially related to formulation differences. To what extent the present 
findings relate to clinical efficacy remains, however, to be determined. 
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Clinical Significance 
Clinical research that investigates fluoride release patterns into saliva and biofilm fluid 
from different FV products is insufficient. More research is needed to investigate 
different FV formulations for their efficacy in order to help clinicians make better 
evidence based treatment choices. 
 
 
Introduction 
Topical fluorides have been shown to be efficacious in the prevention of caries [1] 
with fluoride varnishes (FV) containing 5% sodium fluoride being recommended as the 
primary choice for in-office dental caries prevention [2]. A large number of FV with 
varying fluoride concentrations and compounds, vastly different formulations and often 
containing ingredients being attributed cariostatic properties in their own right (e.g. 
xylitol, calcium compounds) are now commercially available. Comparative caries clinical 
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trials of these different FV, however, have not been conducted to date and only very few 
FV (three according to the present authors’ review) have ever been evaluated for their 
efficacy clinically.[3] 
As caries clinical trials are not only time- and resource-consuming but also put an 
unnecessary burden on participants, the study of clinically validated surrogate measures 
for efficacy is now commonly used by researchers. Current models on the cariostatic 
action of fluoride emphasize the significance of maintaining cariostatic levels of fluoride 
in oral fluids, namely saliva and dental biofilm [4]. Therefore, studying fluoride 
concentration increase in saliva and dental biofilm following the administration of topical 
fluoride is one way to relate to potential clinical efficacy as it can be indicative of 
fluoride levels in the aqueous phase available for interaction with the tooth structure 
during de- and remineralization [5, 6]. 
Very few studies on the kinetics of fluoride in saliva and biofilm following FV 
application have been reported. Two studies reported significant elevations in whole 
saliva fluoride concentration that persisted for up to 6h [7] or 24h [8], respectively. A 
fluoride dose-response was also established [7]. The sole study concerned with fluoride 
in biofilm was able to demonstrate slightly increased fluoride concentrations for up to 30 
days after application which depended on the type of varnish. This study also suggested 
different patterns of fluoride retention for different varnishes [9]. The two comparative 
studies [7, 9], however, investigated FV of different fluoride concentrations and 
compounds (i.e. 5% sodium fluoride [2.26% F], difluorosilane [0.1% F], sodium and 
calcium fluoride [6% F]), thereby limiting conclusions that can be drawn. 
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As there is a considerable gap in our understanding of how different FV 
formulations of identical fluoride concentration affect intra-oral fluoride retention, the 
present study aimed to investigate fluoride concentrations in biofilm, centrifuged and 
whole saliva as surrogate measures for cariostatic efficacy after a single application of 
three inherently different 5% sodium fluoride FV over a period of 48h after a single 
application. 
 
Subjects, Materials and Methods 
Ethical Aspects and Subjects 
The study protocol for this laboratory analyst-blind, randomized, cross-over, 
three-period study was reviewed and approved by the Indiana University Institutional 
Review Board, #1409221212. The study was conducted at Little Flower Catholic School, 
Indianapolis, IN, USA, in children age seven to eleven years. Informed consent (parents) 
and assent (children) were obtained from all study subjects prior to screening. All 
subjects received oral soft and hard tissue examinations throughout the study. In order to 
participate in the study, subjects had to meet the following inclusion criteria: be between 
seven and eleven years old, have good general and oral health, have at least 16 teeth with 
no cavitated carious lesions, and have no oral soft tissue lesions or active periodontal 
disease including severe gingivitis. Subjects also had to understand and be willing and 
able to comply with the instructions provided during the study which included abstention 
from eating for one hour prior to and for the two-hour duration of the test visit. Potential 
subjects were excluded if they had known or suspected allergy or hypersensitivity to FV 
or any of their listed ingredients, were taking fluoride supplements or other fluoride 
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products for medical purposes (except for fluoride naturally occurring in the diet), and 
were taking prescription antibiotics. 
 
Power Calculation 
Based on a previous study on adults [8], with a sample size of 16 subjects, the 
study had a 80% power to detect a difference of 1.5 for log (area under the curve [AUC]) 
between any two treatments, assuming two-sided tests each conducted at a 5% 
significance level, the within-subject correlation is 0.5, and the standard deviation was 
2.0. To account for 10% dropout, the study enrolled 18 subjects. 
 
Fluoride Varnishes and Washout Toothpaste 
 No experimental fluoride varnish was used in this study. Fluoride varnishes 
contained a standard fluoride level of 5% sodium fluoride, were supplied in single dose 
packages, purchased from a provider of professional healthcare products and used at least 
six months prior to expiration. Fluoride concentration of the FV was not determined prior 
to use. FV packages were weighed before and after treatment application in order to 
calculate the amount of varnish applied. Pertinent information about the three FV used in 
this study can be found in Table 1. Subjects were asked to use fluoride-free toothpaste 
(Fluoride Free Children’s Toothpaste, Tom’s of Maine, Kennebunk, ME, USA) for a 
washout period of two weeks prior to the administration of the first treatment and for the 
duration of the study. A two-week washout period is common in the literature for studies 
involving FV. A study reported that baseline fluoride values returned to values that are 
very close to baseline following a washout period of two weeks [8]. 
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Randomization Procedures and Blinding 
A unique screening number was used for all subjects screened for study 
participation. In addition, the study statistician created a randomization schedule to 
determine the order of treatment application for each subject. Due to the uniqueness of 
each FV (color, flavor, and handling properties) the study investigator had the capability 
to discriminate between varnishes and was therefore blinded only to sample analysis 
rather than varnish application.  
Clinical Procedures and Methodologies 
 The investigator completed an oral soft and hard tissue (OSHT) examination at a 
screening visit to ensure only eligible subjects were enrolled into the study. At all other 
visits an oral soft tissue (OST) exam only was performed. Subjects were instructed not to 
brush their teeth or perform any oral hygiene at home on any morning a biofilm sample 
was collected. 
 Subjects provided a baseline (BL) five-minute, non-stimulated saliva sample, 
followed by collection of an interproximal/buccal biofilm sample from all teeth 
immediately prior to assigned FV treatment. FV treatment was applied on all teeth 
surfaces including buccal occlusal third/lingual/occlusal of posterior teeth and facial, 
incisal, and third/lingual of anterior teeth. The exact amount applied clinically was not 
standardized per se, but care was taken to cover all aforementioned tooth surfaces and the 
weight of applied FV determined (see above). The FV treatment was allowed to set and 
immediately thereafter, saliva samples were collected at 30, 60, and 120 min, and at 24h 
and 48h following the treatment. Approximately 1 mg of interproximal/buccal biofilm 
was collected immediately after each saliva sample. Subjects remained at school 
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throughout the treatment visits. At the end of each visit, the study investigator brushed 
the occlusal surfaces of the child’s teeth with water and a new tooth brush (Oral B 
Indicator Soft, Procter & Gamble, OH, USA). A two week washout period with fluoride-
free toothpaste was observed between treatments to allow fluoride to reach baseline 
levels. 
 
Saliva Collection Procedure 
Unstimulated whole saliva samples were collected at baseline and immediately 
following treatment at 30, 60, and 120 min and at 24h and 48h. Saliva collection was 
initiated by having the subjects swallow all the residual saliva in their mouth, and then let 
saliva pool in their mouths for the five-minute period while their heads were tilted 
forward. As the subjects felt the need to swallow, they expectorated into a plastic re-
sealable collection vial. At the end of the five-minute collection period all remaining 
saliva was expectorated into the plastic vial. Saliva samples were stored at -20°C for later 
fluoride analysis. 
 
Biofilm Collection Procedure 
Immediately before dental biofilm collection, subjects were instructed to swallow 
all remaining saliva and keep their mouth open. Approximately 1 mg of dental biofilm 
was collected from the interproximal and buccal surfaces of teeth of all four quadrants. 
Biofilm samples were collected using a standardized protocol. Pooled biofilm samples 
were collected using a stainless steel periodontal scaler (S. McCall 17/18, Hu- Friedy, 
Illinois, USA) from each interproximal area from buccal aspect and buccal area starting 
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from the upper right quadrant to the upper left, lower left and ending in lower right 
quadrant. The pooled biofilm sample was transferred into a plastic strip. 
 
Biofilm Sample Preparation 
Prior to biofilm sample collection, special centrifuge tubes were constructed by 
heat sealing 10 microliter (μl) micropipette tips. They were filled with heavy mineral oil 
(Mineral Oil, Heavy (USP/FCC) Fisher Chemical, Fisher Scientific, USA). 
Microcentrifuge tubes containing the plastic strip and biofilm sample were centrifuged 
for 10 min at 10,000 rpm (4,000g) at 4°C [10]. Partially oil-filled fine glass micro 
pipettes were used to recover small aliquots (approx. 5 nl) from the centrifuged tube 
under a microscope. 
 
Biofilm Fluid Fluoride Analysis 
The micro analytical method was used to analyze biofilm fluid samples for 
fluoride content [11]. Samples were placed, under mineral oil, on the surface of a 
specially constructed inverted F electrode. Mineral oil was used to prevent evaporation. 
Total ionic strength adjusting solution (TISAB III) was added to the samples in a ratio of 
9:1. The tip of a micro-reference electrode was placed in contact with the sample to 
complete the circuit.  
Triplicate analyses were performed on each pooled biofilm fluid sample. Biofilm 
fluid fluoride was expressed as µg F/ml which was calculated by comparison to a 
standard fluoride curve, constructed the same day of the analysis. 
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Saliva Analysis 
Each saliva sample was analyzed as whole and centrifuged saliva for fluoride 
concentration. A 1.4 ml aliquot of each thawed and vortexed saliva sample was 
centrifuged for 10 min at 10,000 rpm (4,000 g) at 7°C (centrifuged saliva) or analyzed for 
fluoride content without centrifugation (whole saliva). Analysis of saliva was conducted 
using a modification of the hexamethyl-disiloxane (HMDS) microdiffusion method [12] 
as modified recently [13]. One ml of centrifuged saliva sample was pipetted into plastic 
Petri dishes (Falcon 15-cm plastic Petri dishes), adding enough deionized water to bring 
final volume in each Petri dish to 3.0 ml. A 0.05 sodium hydroxide analytical reagent 
(NaOH), 50 microliters (μl) trap solution was placed in five drops on the Petri dish lid 
and after the addition of 1 ml of sulfuric acid (H2SO4) saturated with HMDS through a 
small hole in the lid of the Petri dish, each dish was immediately tightly sealed with 
petroleum jelly. During overnight diffusion, fluoride was released by acid hydrolysis and 
was trapped in NaOH. The trap was recovered and buffered to pH 5.2 with 25 μl acetic 
acid (CH3COOH.). The recovered solution was adjusted to a final volume of 100 ml with 
deionized water. Analyses were performed in sets of approximately 40 samples. Fluoride 
was measured using a fluoride combination electrode (Model 9609BNWP, Orion 
Research, Boston, MA, USA) and meter. The fluoride content (μg F) of the samples was 
calculated from a standard curve constructed from fluoride standards and microdiffused 
at the same time as the samples. 
The amount of total fluoride in the samples was calculated based on the amount of 
fluoride divided by the volume of the sample and expressed as μg F/ml of sample. 
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Statistical Analysis  
For saliva, a second analyst examined 10% of the samples to assess inter-
examiner agreement. Intra-examiner repeatability and inter-examiner agreement of the 
fluoride measurements were evaluated using intraclass correlation coefficients. AUC was 
calculated using the trapezoidal method. Statistical analysis for AUC was performed 
using a linear mixed-effects model suitable for a crossover design. The model included 
factors for treatment sequence and baseline fluoride level as covariates, treatment and 
period as fixed factors, with subject as random factor. Pair-wise comparisons among the 
three treatments were made if the treatment main effect was significant, with no multiple 
comparisons adjustment for the individual pair-wise tests. Analyses of the individual 
collection times were made using similar models, with additional factors for time and the 
treatment-by-time interaction. Correlation coefficients were calculated to evaluate the 
associations among the fluoride measurements and between the fluoride measurements 
and amount of varnish applied. Analyses used natural log-transformed data to satisfy the 
model assumptions, and results are presented after transformation back to the original 
scale. All analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC). 
 
Results 
The results include data from 18 subjects as all subjects completed the study. No 
adverse events were reported. After all biological samples were collected and analyzed 
for fluoride, a thorough data review was conducted and potential outliers due to, for 
example, protocol violations, identified. Two subjects were most likely exposed to a 
fluoride source other than the applied FV close to saliva sampling at 24h. Data analyses 
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were performed with and without potential outlier values and the conclusions were nearly 
identical. Therefore, only the results from the test without the outliers are presented here. 
Intra-examiner repeatability (ICC=0.93) and inter-examiner agreement (ICC=0.96) of the 
fluoride measurements were both acceptable. The weight of applied FV (Table 2) varied 
between products, as considerably less CS was necessary to coat all tooth surfaces than 
EP and V (p<0.0001), however, applied amounts of EP and V were not different from 
each other (p=0.23). 
 
Fluoride Data 
 Fluoride levels found in biofilm fluid, centrifuged and whole saliva are shown in 
Figure 4. The baseline fluoride values ranged from 0.20 to 0.80 ppm in biofilm fluid and 
from 0.02 to 0.03 ppm in centrifuged saliva. In general, all values returned to baseline or 
close to baseline levels 24h after FV treatments.  
 
Fluoride Retention (Area Under the Curve; AUC) 
The fluoride levels found over time can be found in Figure 1 (biofilm fluid), 
Figure 2 (centrifuged saliva) and Figure 3 (whole saliva). V had significantly higher 
biofilm fluid fluoride AUC than CS and EP (p<0.02) but CS and EP were not 
significantly different from each other. EP had significantly lower centrifuged saliva 
fluoride AUC than CS and V (p<0.0008) but CS and V had nearly identical values and 
were not significantly different from each other (p=0.86). No significant treatment effect 
was found for whole saliva fluoride AUC (p=0.79).  
 
Time Point Comparisons 
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Comparisons among FV at specific time points were also investigated. The time-
by-treatment interaction was significant only for biofilm fluid fluoride and centrifuged 
saliva. At 30 minutes, EP had significantly lower plaque fluid fluoride than CS 
(p=0.0449) and V (p=0.0006) but CS and V were not different from each other (p=0.16). 
At 60 minutes EP (p=0.0045) and CS (p=0.0353) had significantly lower plaque fluid 
fluoride than V but EP and CS were not different from each other (p=0.48). No treatment 
effect was found at baseline (p=0.88), 120 minutes (p=0.11), 24 hours (p=0.55), or 48 
hours (p=0.40). EP had significantly lower centrifuged saliva fluoride than CS and V at 
30 min (p≤0.0033), at 60 min (p<0.0001), and at 120 min (p≤0.005); EP was not 
significantly different (p≥0.49) from CS or V at baseline, 24h, or 48h. CS and V did not 
have significantly different centrifuged saliva fluoride regardless of time (p=0.89).    
 
Centrifuged Saliva 
For all FV under investigation, centrifuged saliva fluoride was significantly 
higher at 30 min than at any other time (p≤0.0001), followed by 60 min (p≤0.0001) and 
120 min (p≤0.0001), with no significant differences among baseline, 24h, and 48h. 
 
Biofilm Fluid 
It was found that at 30 min EP had significantly lower biofilm fluid fluoride than 
CS and V (p<0.05) but CS and V were not different from each other (p=0.16). At 60 min, 
EP and CS had significantly lower biofilm fluid fluoride than V but EP and CS were not 
different from each other. No treatment effect was found at baseline (p=0.88), 120 min 
(p=0.11), 24h (p=0.55), or 48h (p=0.40). For CS, biofilm fluid fluoride was significantly 
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higher at 30 min than at any other time (p<0.01), followed by 60 and 120 min 
(p<0.0001), with no significant differences among baseline, 24h, and 48h (p=0.19 for 
baseline vs. 24h, p=0.59 for baseline vs. 48h, p=0.41 for 24 vs. 48h) or between 60 and 
120 min (p=0.70). For EP, biofilm fluid fluoride was significantly higher for 30, 60, and 
120 min compared to baseline, 24h, and 48h (p<0.0001), while there were no differences 
among baseline, 24h, and 48h (p=0.18 for baseline vs. 24h, p=0.65 for baseline vs. 48h, 
p=0.33 for 24 vs. 48h) or among 30, 60, and 120 min (p=0.26 for 30 vs. 60 min, p=0.78 
for 30 vs. 120 min, p=0.29 for 60 vs 120 min). For V, biofilm fluid fluoride was 
significantly higher for 30, 60, and 120 min compared to baseline, 24h, and 48h 
(p<0.0001), and higher for 30 than 120 min (p=0.0030), while there were no differences 
among baseline, 24h, and 48h (p=0.44 for baseline vs. 24h, p=0.82 for baseline vs. 48h, 
p=0.24 for 24 vs 48h) and no differences between 60 and 30 min (p=0.11) or 120 min 
(p=0.21). 
 
Correlations between Study Variables 
Whole and centrifuged saliva fluoride AUC were strongly correlated for CS 
(r=0.84; p=<.0001), EP (r=0.82; <.0001), and V (r=0.88; <.0001). Biofilm fluid fluoride 
AUC was moderately correlated with whole saliva fluoride AUC (r=0.44; p=0.09) and 
centrifuged saliva fluoride AUC (r=0.44; p=0.08) for CS but not for the other two 
treatments. Many of the individual time points had moderate to high correlations between 
whole and centrifuged saliva fluoride, but biofilm fluid fluoride was rarely associated 
with whole or centrifuged saliva fluoride at the individual time points. 
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Whole saliva fluoride AUC was moderately correlated (r=0.62) with the amount 
of FV applied for EP. None of the other fluoride AUC measurements were associated 
with the amount of FV applied. 
 
Discussion 
The present in vivo study aimed to compare fluoride retention and clearance from 
three commercially available FV. The design took into account previous findings [7, 9] 
by simultaneously studying fluoride in biofilm and saliva rather than in isolation. The 
study was conducted in children (7-11 years) as they represent the population in which 
FV are being commonly used for caries prevention. The FV were chosen based on their 
varying performances in a range of in vitro studies [14, 15], and because of their different 
composition (Table 1). They present, however, comparable amounts of active ingredient 
as all contained 5% sodium fluoride (equates to 2.26% or 22,600 ppm or 1.19 M 
fluoride). The ‘clinical reference’ FV, Duraphat, was not included as it was not 
commercially available in single dosage packaging at the time the study was planned and 
conducted, and as a recent in vivo pilot study showed virtually no difference in fluoride 
release into centrifuged and whole saliva compared to V [16, 17]. The choice of 
biomarkers for cariostatic efficacy, fluoride in biofilm fluid and centrifuged saliva, was 
based on the mode of action of other topical fluorides [4, 6]. Fluoride in whole saliva was 
also investigated to understand the potential role of formulation components (e.g. calcium 
compounds) on fluoride sequestration in line with a recent study [18]. The most 
commonly used biomarker for FV efficacy in the past was enamel fluoride uptake [19, 
20]. However it was not studied here due to its invasive nature and as the present study 
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was also concerned with fluoride clearance patterns in addition to its retention. It should 
also be noted that the role of tooth-bound fluoride in the caries process is limited 
especially in relation to extrinsically provided fluoride, such as that present in biofilm 
fluid and therefore the choice had been made to study this variable [21]. 
The present study has shown that commercially available FV differ in their ability 
to fluoridate oral reservoirs. An approximate three-fold difference in mean biofilm fluid 
fluoride AUC was noted between two of the tested FV (V vs. EP) which was also 
mirrored, albeit to a lesser extent, in centrifuged saliva. Fluoride release patterns into 
biofilm fluid and saliva were, however, very similar among FV with the highest fluoride 
concentration being observed for the first post-application sample that was collected. 
Likewise, no differences were observed for whole saliva. 
The significantly lower levels of fluoride in both centrifuged saliva and biofilm fluid 
from EP may be related to the authors’ subjective finding of its lower viscosity compared 
to the other FV under investigation (viscosity differences also explain the varying 
amounts of applied FV). EP adhered less to teeth in the process of application, is 
therefore more likely to seep away from the application zone and, consequently, may be 
swallowed before all of its fluoride is released. Another potential explanation could lie in 
its composition (Table 1). EP contains calcium and phosphate providing a source of ionic 
calcium. Upon contact of EP with saliva, calcium and fluoride are likely to be ionized 
and capable of forming compounds of poor solubility. This may explain the present 
results for whole saliva which did not mirror those of centrifuged saliva. Analysis of 
biofilm solids, not conducted presently, could have further confirmed this hypothesis.  
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We must keep in mind that analysis of the supernatant after centrifuging saliva has the 
advantage of eliminating any protein globules that act as an interference in the highly 
sensitive F ion selective electrode.[22] As we can see from our own findings that 
differences between FV were hard to assess when whole saliva was investigated in 
comparison to centrifuged saliva. However, we must keep in mind that while we are 
eliminating interferences, we are missing a significant portion of fluoride that resides in 
the sediment. Therefore, some researches prefer to analyze the sediment in addition to 
analyzing the supernatant.[23] 
The findings for EP in comparison to the other tested FV highlight discrepancies 
between laboratory [14, 24, 25] and the present in vivo observations. Our results are in 
agreement with Downey et al. where we both believe that EP’s consistency specifically 
its low viscosity resulted in rapid dissociation of the aforementioned FV in the oral 
environment before it could reach its potential. This is in contrast with its behavior in 
laboratory settings where we believe that EP was more effective in fluoride release due to 
the controlled and confined settings in an in vitro experimental design.[3] Because of 
this, caution is recommended when drawing conclusions about clinical efficacy from in 
vitro studies. However, even the present clinical findings need to be validated as 
surrogate measures for clinical efficacy for caries prevention. Our understanding of the 
mode of action of FV is still poor and is largely derived from other topical fluorides 
which are applied more frequently and contain significantly less fluoride, highlighting the 
need for longitudinal, mechanistic studies. 
It should be noted here that FV was not directly applied to areas from which 
biofilm was later collected (in line with a recent mechanistic study [26]; i.e. fluoride had 
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to migrate from FV applied in the vicinity of biofilm to the collection sites. While this 
may be considered a flaw in the study design, the prolonged retention of FV on the tooth 
surface makes it otherwise impossible to study immediate effects of FV on biofilm 
fluoridation. However, as FV are rather viscous their penetration into pits, fissures and to 
proximal surfaces is limited. Fluoride delivered to these areas from FV is likely due to 
migration, thereby supporting the presently chosen design. 
Another noteworthy finding of the present study is the significantly higher biofilm 
fluid fluoride AUC for V. This varnish contains fTCP, a promising calcium compound to 
promote enamel fluoridation and remineralization [27]. The calcium added to the 
formulation possibly acts as a scavenger for fluoride and thereby may aid in increasing 
the amount of fluoride reservoirs in biofilm fluid [28, 29]. Although similar results could 
have been expected between V and EP, fTCP is only sparingly soluble thereby limiting 
the release of ionic calcium. Inherent formulation differences between EP and V may 
further explain their different abilities to deliver fluoride, albeit to an unknown extent. In 
hindsight, a study on experimental FV formulations varying in fewer formulation 
parameters than those evaluated presently would have been advantageous as firmer 
conclusions about the potential role of formulation excipients could have been drawn. 
However, the tested FV are commercially available and being used by dental 
professionals in the prevention of caries in their patients, thereby adding translational 
value to the present study. 
Fluoride release patterns somewhat mirrored those of other topical fluoride 
delivery vehicles [30]. A greater tenacity for fluoride retention in comparison to 
dentifrices was noted nonetheless which may be explained by the varnish excipients 
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providing some sort of a slow-release delivery system. Pharmacokinetic modeling was, 
however, not considered presently as no data were collected between 0 and 30 min, and 2 
and 24h time points. The concentration of fluoride in saliva was only moderately 
correlated with biofilm fluid fluoride at the examined time points. A previous study found 
a strong linear correlation between fluoride concentrations in saliva and biofilm fluid at 
30 and 60 min after administration of a sodium fluoride rinse [31]. The strong correlation 
may be attributed to differences in the delivery method. Rinses are swished in the mouth 
and thereby interact to a greater extent with the oral soft tissues, a major site for fluoride 
retention [32], whereas FV are applied only to the teeth and the fluoride needs to be 
released from a resin matrix. 
The present study has shown that FV vary greatly in their ability to deliver 
fluoride intra-orally which may be explained by differences in their formulations. To 
what extend the present findings relate to clinical efficacy remains, however, to be 
determined. In light of the aforementioned and present clinical findings, there is an urgent 
need to not only develop efficacy guidelines for FV to set minimum standards but also to 
support research on how to further improve FV formulations. 
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Legends 
 
Figure 1. Mean concentration of fluoride release into biofilm fluid from fluoride 
varnishes as a function of time (log10 scale for better clarity). Mean +/- SE. 
Figure 2. Mean concentration of fluoride release into centrifuged saliva from fluoride 
varnishes as a function of time (log10 scale for better clarity).  Mean +/- SE. 
Figure 3. Mean concentration of fluoride release into whole saliva from fluoride 
varnishes as a function of time (log10 scale for better clarity). Mean +/- SE. 
Figure 4. Means and standard errors of fluoride concentrations (AUC) in biofilm fluid, 
centrifuged and whole saliva (log10 scale for better clarity). 
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Error bars = standard errors 
Different letters highlight statistically significant differences 
 
Figure 4 
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Table 1. Test products. 
Fluoride 
Varnish 
Manufacturer 
Fluoride Source 
and 
Concentration 
Carrier 
Other Active 
Ingredient 
 
Enamel Pro Premier Dental 5% NaF Rosin 
Amorphous 
calcium 
phosphate 
(ACP), Xylitol 
CavityShield 3M ESPE 5% NaF 
Rosin, Polyamide 
Resin 
N/A 
Vanish 3M ESPE 5% NaF 
Pentaerythritol 
glycerol ester of 
Rosin 
Functionalized 
tri-calcium 
phosphate 
(fTCP), Xylitol 
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Table 2. Mean amount of treatment applied in grams and SD 
Table 2. Mean amount of FV applied per subject 
Fluoride Varnish N Grams, Mean (SD) 
CS 18 0.13 (0.04)b 
EP 18 0.24 (0.06)a 
V 18 0.27 (0.11)a 
Different letters highlight statistically significant differences 
 
